10-Q Filing

VAREX IMAGING CORP CIK: 1681622 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001681622-17-000012`
Period End Date	20170331
Filing Date	20170512
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	var-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 80 Cash Flow Statement 78 Stockholders Equity 18 Comprehensive Income 32

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$38.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$79.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.50M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$122.20M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$120.70M	USD	Point-in-time
Common stock, par value per share (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value per share (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories, net	`InventoryNet`	$212.10M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$197.40M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.80M	USD	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	37.54M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$12.10M	USD	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$424.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$359.90M	USD	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	37.54M	shares	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$119.10M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$108.90M	USD	Point-in-time
Goodwill	`Goodwill`	$74.70M	USD	Point-in-time
Goodwill	`Goodwill`	$74.70M	USD	Point-in-time
Intangibles assets	`IntangibleAssetsNetExcludingGoodwill`	$18.00M	USD	Point-in-time
Intangibles assets	`IntangibleAssetsNetExcludingGoodwill`	$20.70M	USD	Point-in-time
Investments in privately held companies	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$50.10M	USD	Point-in-time
Investments in privately held companies	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$49.30M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$5.50M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.40M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.40M	USD	Point-in-time
Total assets	`Assets`	$692.80M	USD	Point-in-time
Total assets	`Assets`	$622.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$41.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$46.40M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$23.90M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$74.30M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtCurrent`	$15.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtCurrent`	-	USD	Point-in-time
Deferred revenues	`DeferredRevenueCurrent`	$10.10M	USD	Point-in-time
Deferred revenues	`DeferredRevenueCurrent`	$12.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$145.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$77.80M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$187.30M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Deferred tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$3.00M	USD	Point-in-time
Deferred tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$3.70M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.30M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.20M	USD	Point-in-time
Total liabilities	`Liabilities`	$86.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$339.00M	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$10.30M	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$10.30M	USD	Point-in-time
Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Common stock, $.01 par value: 150,000 shares authorized, 37,538,165 issued and outstanding as of March 31, 2017; none issued and outstanding as of September 30, 2016	`CommonStockValueOutstanding`	$400.00K	USD	Point-in-time
Common stock, $.01 par value: 150,000 shares authorized, 37,538,165 issued and outstanding as of March 31, 2017; none issued and outstanding as of September 30, 2016	`CommonStockValueOutstanding`	-	USD	Point-in-time
Net parent investment	`ParentCompanyInvestment`	$526.00M	USD	Point-in-time
Net parent investment	`ParentCompanyInvestment`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$333.50M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$9.60M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	-	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$526.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$343.50M	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and Varex stockholders' equity	`LiabilitiesAndStockholdersEquity`	$622.40M	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and Varex stockholders' equity	`LiabilitiesAndStockholdersEquity`	$692.80M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$149.80M	USD	1 Quarter
Revenues	`Revenues`	$154.80M	USD	1 Quarter
Revenues	`Revenues`	$296.60M	USD	2 Qtrs
Revenues	`Revenues`	$312.20M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$97.20M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$90.70M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$180.40M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$195.80M	USD	2 Qtrs
Gross margin	`GrossProfit`	$116.20M	USD	2 Qtrs
Gross margin	`GrossProfit`	$59.10M	USD	1 Quarter
Gross margin	`GrossProfit`	$57.60M	USD	1 Quarter
Gross margin	`GrossProfit`	$116.40M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$25.60M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$13.10M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$14.40M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$27.70M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$42.90M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$20.80M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$19.70M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$46.80M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$68.50M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$34.10M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$74.50M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$33.90M	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$25.20M	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$41.90M	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$47.70M	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$23.50M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$300.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	-	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$100.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$100.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.60M	USD	2 Qtrs
Interest expense	`InterestExpense`	$800.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$500.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$300.00K	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-100.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-1.10M	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$100.00K	USD	1 Quarter
Interest and other income (expense), net	`NonoperatingIncomeExpense`	$-1.20M	USD	2 Qtrs
Interest and other income (expense), net	`NonoperatingIncomeExpense`	$-1.60M	USD	2 Qtrs
Interest and other income (expense), net	`NonoperatingIncomeExpense`	$-300.00K	USD	1 Quarter
Interest and other income (expense), net	`NonoperatingIncomeExpense`	$-1.10M	USD	1 Quarter
Earnings before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$40.70M	USD	2 Qtrs
Earnings before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$46.10M	USD	2 Qtrs
Earnings before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$24.90M	USD	1 Quarter
Earnings before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$22.40M	USD	1 Quarter
Taxes on earnings	`IncomeTaxExpenseBenefit`	$14.50M	USD	2 Qtrs
Taxes on earnings	`IncomeTaxExpenseBenefit`	$7.40M	USD	1 Quarter
Taxes on earnings	`IncomeTaxExpenseBenefit`	$17.10M	USD	2 Qtrs
Taxes on earnings	`IncomeTaxExpenseBenefit`	$10.10M	USD	1 Quarter
Net earnings	`ProfitLoss`	$26.20M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$29.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$15.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$14.80M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$100.00K	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$100.00K	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$100.00K	USD	2 Qtrs
Net earnings attributable to Varex	`NetIncomeLoss`	$15.00M	USD	1 Quarter
Net earnings attributable to Varex	`NetIncomeLoss`	$26.10M	USD	2 Qtrs
Net earnings attributable to Varex	`NetIncomeLoss`	$14.70M	USD	1 Quarter
Net earnings attributable to Varex	`NetIncomeLoss`	$28.90M	USD	2 Qtrs
Earnings per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.40	USD	1 Quarter
Earnings per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.39	USD	1 Quarter
Earnings per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.70	USD	2 Qtrs
Earnings per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.77	USD	2 Qtrs
Earnings per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.69	USD	2 Qtrs
Earnings per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.39	USD	1 Quarter
Earnings per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.77	USD	2 Qtrs
Earnings per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.40	USD	1 Quarter
Weighted average number of shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.50M	shares	1 Quarter
Weighted average number of shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.40M	shares	1 Quarter
Weighted average number of shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.50M	shares	2 Qtrs
Weighted average number of shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.40M	shares	2 Qtrs
Weighted average number of shares outstanding,dDiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.70M	shares	2 Qtrs
Weighted average number of shares outstanding,dDiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.80M	shares	2 Qtrs
Weighted average number of shares outstanding,dDiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.80M	shares	1 Quarter
Weighted average number of shares outstanding,dDiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.70M	shares	1 Quarter

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$29.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$15.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$14.80M	USD	1 Quarter
Net earnings	`ProfitLoss`	$26.20M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$4.60M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$3.60M	USD	2 Qtrs
Depreciation	`Depreciation`	$8.50M	USD	2 Qtrs
Depreciation	`Depreciation`	$4.40M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.50M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.30M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$2.90M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$2.60M	USD	2 Qtrs
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$6.90M	USD	2 Qtrs
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$9.10M	USD	2 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$400.00K	USD	2 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-300.00K	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	-	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-600.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.10M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-300.00K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$11.50M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$15.20M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.80M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$100.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.70M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$7.30M	USD	2 Qtrs
Accrued operating liabilities and other long-term operating liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-6.90M	USD	2 Qtrs
Accrued operating liabilities and other long-term operating liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.40M	USD	2 Qtrs
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$-2.00M	USD	2 Qtrs
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$-100.00K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$26.90M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$33.00M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.10M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.70M	USD	2 Qtrs
Sale of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	-	USD	2 Qtrs
Sale of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$8.60M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.50M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.70M	USD	2 Qtrs
Net transfers (to) from parent	`ProceedsFromContributionsFromAffiliates`	$14.50M	USD	2 Qtrs
Net transfers (to) from parent	`ProceedsFromContributionsFromAffiliates`	$1.00M	USD	2 Qtrs
Distribution to Varian Medical Systems, Inc.	`ProceedsFromContributionsFromParent`	-	USD	2 Qtrs
Distribution to Varian Medical Systems, Inc.	`ProceedsFromContributionsFromParent`	$-200.00M	USD	2 Qtrs
Taxes related to net share settlement of equity awards	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$-1.90M	USD	2 Qtrs
Taxes related to net share settlement of equity awards	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	-	USD	2 Qtrs
Borrowings under credit agreements	`ProceedsFromLongTermLinesOfCredit`	$206.00M	USD	2 Qtrs
Borrowings under credit agreements	`ProceedsFromLongTermLinesOfCredit`	-	USD	2 Qtrs
Repayments of borrowing under credit agreements	`RepaymentsOfLongTermLinesOfCredit`	-	USD	2 Qtrs
Repayments of borrowing under credit agreements	`RepaymentsOfLongTermLinesOfCredit`	$3.80M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$600.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$700.00K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.10M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.00M	USD	2 Qtrs
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$100.00K	USD	2 Qtrs
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$700.00K	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$17.50M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$43.10M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$79.60M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$38.10M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$36.50M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$20.60M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$36.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$20.60M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$38.10M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$79.60M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	-	USD	2 Qtrs
Cash paid for interest	`InterestPaid`	$900.00K	USD	2 Qtrs
Cash paid for income tax	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid for income tax	`IncomeTaxesPaid`	-	USD	2 Qtrs
Purchases of property, plant and equipment financed through accounts payable	`FairValueOfAssetsAcquired`	$2.60M	USD	2 Qtrs
Purchases of property, plant and equipment financed through accounts payable	`FairValueOfAssetsAcquired`	$3.60M	USD	2 Qtrs
Transfers of property, plant and equipment from Varian Medical Systems, Inc.	`ContributionOfProperty`	-	USD	2 Qtrs
Transfers of property, plant and equipment from Varian Medical Systems, Inc.	`ContributionOfProperty`	$14.70M	USD	2 Qtrs
Distribution payable to Varian Medical Systems, Inc.	`DistributionPayabletoAffiliate`	-	USD	2 Qtrs
Distribution payable to Varian Medical Systems, Inc.	`DistributionPayabletoAffiliate`	$27.10M	USD	2 Qtrs
Other non-cash transfers from parent	`OtherNoncashTransfersfromParent`	$12.40M	USD	2 Qtrs
Other non-cash transfers from parent	`OtherNoncashTransfersfromParent`	-	USD	2 Qtrs

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Common stock, shares, outstanding, beginning balance	`CommonStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, shares, outstanding, beginning balance	`CommonStockSharesOutstanding`	37.54M	shares	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquity`	$526.00M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquity`	$343.50M	USD	Point-in-time
Net earnings	`ProfitLoss`	$29.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$15.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$14.80M	USD	1 Quarter
Net earnings	`ProfitLoss`	$26.20M	USD	2 Qtrs
Net transfers from parent	`NetTransfersfromParent`	$-20.90M	USD	2 Qtrs
Distribution to Varian Medical Systems	`DistributionstoParent`	$229.70M	USD	2 Qtrs
Conversion of net parent investment into common stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	2 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$600.00K	USD	2 Qtrs
Value of shares withheld on vesting of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$1.90M	USD	2 Qtrs
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.40M	USD	2 Qtrs
Common stock, shares, outstanding, ending balance	`CommonStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, shares, outstanding, ending balance	`CommonStockSharesOutstanding`	37.54M	shares	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquity`	$526.00M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquity`	$343.50M	USD	Point-in-time

Comprehensive Income 32 line items

Line Item	Tag	Value	Unit	Period
Unrealized holding gain on securities arising during period, tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	2 Qtrs
Unrealized holding gain on securities arising during period, tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-100.00K	USD	2 Qtrs
Net earnings	`ProfitLoss`	$29.00M	USD	2 Qtrs
Reclassification adjustment from AOCI for write-down of securities, tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesTax`	$-200.00K	USD	2 Qtrs
Net earnings	`ProfitLoss`	$15.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$14.80M	USD	1 Quarter
Reclassification adjustment from AOCI for write-down of securities, tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesTax`	-	USD	2 Qtrs
Net earnings	`ProfitLoss`	$26.20M	USD	2 Qtrs
Change in unrealized loss, net of tax benefit of $0 and $0.1 during the six months ended March 31, 2017 and April 1, 2016, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Change in unrealized loss, net of tax benefit of $0 and $0.1 during the six months ended March 31, 2017 and April 1, 2016, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-300.00K	USD	2 Qtrs
Change in unrealized loss, net of tax benefit of $0 and $0.1 during the six months ended March 31, 2017 and April 1, 2016, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	2 Qtrs
Change in unrealized loss, net of tax benefit of $0 and $0.1 during the six months ended March 31, 2017 and April 1, 2016, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Reclassification adjustments, net of tax expense of $0 and ($0.2) during the six months ended March 31, 2017 and April 1, 2016, respectively	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	1 Quarter
Reclassification adjustments, net of tax expense of $0 and ($0.2) during the six months ended March 31, 2017 and April 1, 2016, respectively	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$-400.00K	USD	2 Qtrs
Reclassification adjustments, net of tax expense of $0 and ($0.2) during the six months ended March 31, 2017 and April 1, 2016, respectively	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	1 Quarter
Reclassification adjustments, net of tax expense of $0 and ($0.2) during the six months ended March 31, 2017 and April 1, 2016, respectively	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	2 Qtrs
Other comprehensive earnings, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$100.00K	USD	2 Qtrs
Other comprehensive earnings, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	2 Qtrs
Other comprehensive earnings, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	1 Quarter
Other comprehensive earnings, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	1 Quarter
Comprehensive earnings	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$15.00M	USD	1 Quarter
Comprehensive earnings	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$29.10M	USD	2 Qtrs
Comprehensive earnings	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$26.20M	USD	2 Qtrs
Comprehensive earnings	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$14.80M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$100.00K	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$100.00K	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$100.00K	USD	2 Qtrs
Comprehensive earnings attributable to Varex	`ComprehensiveIncomeNetOfTax`	$29.00M	USD	2 Qtrs
Comprehensive earnings attributable to Varex	`ComprehensiveIncomeNetOfTax`	$14.70M	USD	1 Quarter
Comprehensive earnings attributable to Varex	`ComprehensiveIncomeNetOfTax`	$15.00M	USD	1 Quarter
Comprehensive earnings attributable to Varex	`ComprehensiveIncomeNetOfTax`	$26.10M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.